| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1377249 | Bioorganic & Medicinal Chemistry Letters | 2006 | 5 Pages |
Abstract
3-Benzimidazol-2-yl-1H-indazole analogs were developed as inhibitors of receptor tyrosine kinases (RTK). The synthesis and SAR of this series is reported.
Graphical abstractThe synthesis and SAR of 3-benzimidazol-2-yl-1H-indazole analogs developed as inhibitors of receptor tyrosine kinases (RTK) is reported.Figure optionsDownload full-size imageDownload as PowerPoint slide
Keywords
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Christopher M. McBride, Paul A. Renhowe, Carla Heise, Johanna M. Jansen, Gena Lapointe, Sylvia Ma, Ramon Piñeda, Jayesh Vora, Marion Wiesmann, Cynthia M. Shafer,